Form 4: HealthEquity Executive Michael Fiore Reports Stock Transactions

EVP and Chief Commercial Officer of HealthEquity, Michael Fiore, reports acquisition and disposal of company stock.

Summary

• Michael Fiore, EVP and Chief Commercial Officer of HealthEquity, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On April 2, 2025, Fiore acquired 15,495 shares of common stock at $0.
• On April 3, 2025, Fiore disposed of 4,839 shares of common stock at a price of $83.8739.
• Following these transactions, Fiore beneficially owns 65,536 shares of HealthEquity common stock.
• The reported transactions include the vesting of restricted stock units, which convert into common stock.
• The restricted stock units vest in installments, starting with 25% on April 1, 2026, and subsequent quarterly installments.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The document does not contain specific forward-looking statements, but it outlines the vesting schedule for restricted stock units, indicating future equity compensation for the reporting person.

Industry Context

Form 4 filings are standard practice for reporting insider transactions, providing transparency to the market regarding the buying and selling activities of company executives and directors. This allows investors to gain insight into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may be interested in the transactions of company executives as an indicator of management's confidence in the company's future prospects.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transaction, HealthEquity, HQY, Michael Fiore, Executive Compensation, Restricted Stock Units